newsfilter
← Latest News
GlobeNewswire·

Otonomy Reports First Quarter 2021 Financial Results and Provides Corporate Update

OTO-313 Phase 2 trial in tinnitus initiated with results expected in mid-2022 OTO-413 Phase 1/2 trial expansion in hearing loss expected to start in second quarter of 2021 with results anticipated in mid-2022 OTO-825 IND-enabling activities underway w